+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Medical Ophiopogon Japonicus Extract Market - Global Forecast 2026-2032- Product Image
Medical Ophiopogon Japonicus Extract Market - Global Forecast 2026-2032- Product Image
Sale

Medical Ophiopogon Japonicus Extract Market - Global Forecast 2026-2032

  • Report

  • 188 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6283227
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Medical Ophiopogon Japonicus Extract: Executive Overview

Medical Ophiopogon japonicus extract is derived from the tuber of Ophiopogon japonicus, a botanical used in traditional East Asian medicine and investigated for applications related to respiratory, cardiovascular, inflammatory, metabolic, and supportive care. Its medical relevance depends on authenticated raw materials, consistent extraction, defined chemical markers, and evidence that connects composition with clinical outcomes. The sector is shaped by pharmacopoeial expectations, botanical-drug regulation, quality assurance, and the need to distinguish traditional use from clinically validated indications.

From Traditional Remedy to Standardized Medical Ingredient

The landscape is shifting from experience-based use toward reproducible, evidence-supported products. Manufacturers and researchers are placing greater emphasis on botanical identification, cultivation controls, contaminant testing, extraction parameters, stability, and batch-to-batch chemical profiling. Modern development also increasingly combines traditional knowledge with pharmacology, toxicology, formulation science, and controlled clinical evaluation. These changes raise the importance of traceability and documentation while creating opportunities for standardized extracts with clearly defined therapeutic or supportive roles.

Artificial Intelligence Strengthens Discovery and Quality Control

Artificial intelligence can support the medical Ophiopogon japonicus extract value chain without replacing laboratory or clinical validation. Machine-learning tools can help compare phytochemical profiles, prioritize candidate constituents, analyze scientific literature, identify potential mechanisms, and detect anomalies in chromatographic or manufacturing data. AI-assisted formulation and safety screening may improve research efficiency, while digital traceability can connect cultivation, processing, testing, and release records. Human oversight remains essential because botanical composition varies by genetics, geography, harvest conditions, processing, and extraction method, and algorithmic findings require experimental confirmation.

Regional Insights: Regulation and Traditional-Medicine Integration Shape Adoption

North America emphasizes safety documentation, quality consistency, evidence standards, and clear product classification across pharmaceutical, supplement, and integrative-health channels. Latin America combines interest in medicinal plants with uneven regulatory capacity and a need for stronger cultivation, authentication, and clinical infrastructure. Europe places substantial weight on botanical identity, contaminant limits, claims substantiation, and harmonized quality systems. The Middle East is influenced by pharmaceutical-import requirements, hospital procurement standards, and interest in evidence-based complementary medicine. Africa presents opportunities linked to local biodiversity and healthcare access, alongside challenges in standardized supply, analytical capacity, and regulatory implementation. Asia-Pacific remains central to traditional use, cultivation, processing, research, and product development, with regulatory expectations varying considerably among jurisdictions.

Group Insights: Trade, Standards, and Health-System Coordination

ASEAN markets can benefit from regional cooperation on botanical authentication, good agricultural and collection practices, and mutual understanding of quality documentation, although national rules remain diverse. BRICS members bring substantial research, cultivation, manufacturing, and healthcare capabilities, but coordination is affected by differing regulatory pathways and evidence requirements. The European Union supports structured quality, safety, and claims assessment through coordinated frameworks while retaining national implementation differences. G7 countries generally prioritize rigorous clinical, toxicological, manufacturing, and pharmacovigilance evidence. GCC markets are shaped by centralized procurement, import controls, and quality expectations for pharmaceutical and health products. NATO members do not share a single botanical-drug framework, but their overlapping emphasis on supply resilience, validated manufacturing, and health-security preparedness can influence sourcing and quality strategy.

Country Insights: Diverse Evidence and Regulatory Pathways

Australia emphasizes complementary-medicine regulation, sponsor responsibilities, and evidence appropriate to product claims. Brazil combines established herbal-medicine expertise with requirements for identity, quality, safety, and registration. Canada distinguishes product categories through regulated health-product pathways and expects documented quality and permitted claims. China has deep traditional-use knowledge, domestic research capacity, and formal expectations for standardized traditional medicines. France and Germany operate within European requirements while maintaining strong professional and institutional interest in evidence-based botanical products. India has extensive Ayurvedic and pharmaceutical capabilities, with quality and licensing requirements varying by intended use. Italy and Spain apply European standards alongside active botanical and pharmaceutical sectors. Japan has advanced Kampo expertise and strong expectations for manufacturing consistency. Mexico is influenced by both domestic traditional-medicine practices and North American regulatory considerations. Russia has established pharmacognosy and pharmaceutical research traditions, with market access shaped by national requirements. South Korea combines traditional medicine, biotechnology, and modern clinical research. The United Kingdom applies its own post-EU regulatory arrangements with emphasis on product quality, safety, and substantiated claims. The United States requires careful classification and evidence planning because regulatory obligations differ among drugs, dietary supplements, and other health products.

Action Priorities for Leaders: Build Evidence, Resilience, and Trust

Industry leaders should first define the intended product category, indication, route of administration, and claims before selecting a development pathway. They should secure authenticated plant material, qualify suppliers, document cultivation and harvest conditions, and establish validated analytical methods for identity, marker compounds, impurities, adulterants, and microbial quality. Development programs should connect traditional-use rationale with pharmacology, toxicology, formulation, human safety, and appropriately designed clinical studies. Leaders should also create change-control systems for botanical variability, use digital records to strengthen traceability, and establish pharmacovigilance plans suited to the target jurisdiction. AI should be deployed in bounded, auditable workflows, with laboratory confirmation and governance for data quality, privacy, bias, and model performance. Partnerships with qualified researchers, healthcare professionals, and regulatory specialists can improve credibility and market access.

Research Methodology: Evidence-Led Assessment of a Botanical Medical Market

This executive summary uses the defined market scope of medical Ophiopogon japonicus extract and organizes findings across technology, regulation, supply, healthcare application, and geography. The assessment distinguishes traditional use, preclinical evidence, clinical evidence, and regulatory authorization rather than treating them as equivalent. Regional, group, and country observations are framed around documented differences in botanical-drug regulation, traditional-medicine integration, manufacturing capability, quality expectations, and healthcare systems. No market estimates, market shares, forecasts, or company-specific claims are used. Interpretation should be updated as official monographs, regulatory decisions, peer-reviewed studies, pharmacovigilance records, and validated analytical standards evolve.

Conclusion: Standardization Will Determine Medical Credibility

Medical Ophiopogon japonicus extract sits at the intersection of traditional medicine, botanical science, pharmaceutical manufacturing, and evidence-based care. Its long history of use provides a rationale for research, but durable medical adoption depends on authenticated materials, reproducible composition, credible safety data, clinically relevant evidence, and regulatory alignment. Organizations that treat quality, traceability, transparent claims, and responsible innovation as core capabilities will be better positioned to translate a traditional botanical into dependable medical products across diverse jurisdictions.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Medical Ophiopogon Japonicus Extract Market, by Product Form
7.1. Introduction
7.2. Liquid Extract
7.3. Powder Extract
8. Medical Ophiopogon Japonicus Extract Market, by Extraction Method
8.1. Introduction
8.2. Ethanol Extraction
8.3. Water Extraction
8.4. Supercritical CO2 Extraction
9. Medical Ophiopogon Japonicus Extract Market, by Active Component
9.1. Introduction
9.2. Steroidal Saponin
9.3. Polysaccharide
10. Medical Ophiopogon Japonicus Extract Market, by Dosage Form
10.1. Introduction
10.2. Injectable Formulations
10.3. Oral Formulations
11. Medical Ophiopogon Japonicus Extract Market, by Application
11.1. Introduction
11.2. Respiratory Disease Treatment
11.3. Cardiovascular Support Therapy
11.4. Anti-Inflammatory Treatment
12. Medical Ophiopogon Japonicus Extract Market, by Region
12.1. Introduction
12.2. Asia-Pacific
12.3. North America
12.4. Latin America
12.5. Europe
12.6. Middle East
12.7. Africa
13. Medical Ophiopogon Japonicus Extract Market, by Group
13.1. Introduction
13.2. ASEAN
13.3. GCC
13.4. European Union
13.5. BRICS
13.6. G7
13.7. NATO
14. Medical Ophiopogon Japonicus Extract Market, by Country
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. United Kingdom
14.7. Germany
14.8. France
14.9. Russia
14.10. Italy
14.11. Spain
14.12. China
14.13. India
14.14. Japan
14.15. Australia
14.16. South Korea
15. Competitive Landscape
15.1. Market Share Analysis, 2025
15.2. Market Concentration Analysis, 2025
15.2.1. Concentration Ratio (CR)
15.2.2. Herfindahl Hirschman Index (HHI)
15.3. Recent Developments & Impact Analysis, 2025
15.4. Product Portfolio Analysis, 2025
15.5. Benchmarking Analysis, 2025
16. Company Profiles
16.1. Hubei Biolight Plant Extracts Co., Ltd.
16.2. Hunan Goldliloo Biotech Co., Ltd.
16.3. Hunan Nutra-Science Co., Ltd.
16.4. Hunan Nutraherb Biotech Co., Ltd.
16.5. Nanjing Natural Extracts Co., Ltd.
16.6. Shaanxi Green Bio-Engineering Co., Ltd.
16.7. Shaanxi Huike Botanical Co., Ltd.
16.8. Shaanxi Shouzhong Herbal Co., Ltd.
16.9. Shaanxi Yongyuan Bio-Tech Co., Ltd.
16.10. Shaanxi Zhongxin Natural Products Co., Ltd.
16.11. Tianjin Zhongxin Pharmaceutical Co., Ltd.
16.12. Xi’an Freshway Biotech Co., Ltd.
16.13. Xi’an Lyphar Biotech Co., Ltd.
16.14. Xi’an Realin Biotech Co., Ltd.
16.15. Xi’an Ruiting Biotech Co., Ltd.
16.16. Xi’an Sost Biotech Co., Ltd.
16.17. Zhejiang Jingxin Pharmaceutical Co., Ltd.
16.18. Zhejiang Medicine Co., Ltd.
17. Key Experts
LIST OF FIGURES
FIGURE 1. Global Medical Ophiopogon Japonicus Extract Market, Years Considered for the Study
FIGURE 2. Global Medical Ophiopogon Japonicus Extract Market, Research Design
FIGURE 3. Global Medical Ophiopogon Japonicus Extract Market, Research Framework
FIGURE 4. Global Medical Ophiopogon Japonicus Extract Market, Data Triangulation
FIGURE 5. Global Medical Ophiopogon Japonicus Extract Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Medical Ophiopogon Japonicus Extract Market Size, by Product Form, 2025 vs 2032 (%)
FIGURE 7. Global Medical Ophiopogon Japonicus Extract Market Size, by Product Form, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Medical Ophiopogon Japonicus Extract Market Size, by Extraction Method, 2025 vs 2032 (%)
FIGURE 9. Global Medical Ophiopogon Japonicus Extract Market Size, by Extraction Method, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Medical Ophiopogon Japonicus Extract Market Size, by Active Component, 2025 vs 2032 (%)
FIGURE 11. Global Medical Ophiopogon Japonicus Extract Market Size, by Active Component, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Medical Ophiopogon Japonicus Extract Market Size, by Dosage Form, 2025 vs 2032 (%)
FIGURE 13. Global Medical Ophiopogon Japonicus Extract Market Size, by Dosage Form, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Medical Ophiopogon Japonicus Extract Market Size, by Application, 2025 vs 2032 (%)
FIGURE 15. Global Medical Ophiopogon Japonicus Extract Market Size, by Application, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Medical Ophiopogon Japonicus Extract Market Size, by Region, 2025 vs 2032 (%)
FIGURE 17. Global Medical Ophiopogon Japonicus Extract Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 18. Global Medical Ophiopogon Japonicus Extract Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 19. Global Medical Ophiopogon Japonicus Extract Market Size, by Country, 2025 vs 2032 (%)
FIGURE 20. Global Medical Ophiopogon Japonicus Extract Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 21. Global Medical Ophiopogon Japonicus Extract Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Medical Ophiopogon Japonicus Extract Market Segmentation & Coverage
TABLE 2. Global Medical Ophiopogon Japonicus Extract Market Size, 2017-2032 (USD Million)
TABLE 3. Global Medical Ophiopogon Japonicus Extract Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 4. Global Liquid Extract Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Liquid Extract Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Liquid Extract Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Powder Extract Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Powder Extract Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Powder Extract Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Medical Ophiopogon Japonicus Extract Market Size, by Extraction Method, 2017-2032 (USD Million)
TABLE 11. Global Ethanol Extraction Market Size, by Region, 2017-2032 (USD Million)
TABLE 12. Global Ethanol Extraction Market Size, by Group, 2017-2032 (USD Million)
TABLE 13. Global Ethanol Extraction Market Size, by Country, 2017-2032 (USD Million)
TABLE 14. Global Water Extraction Market Size, by Region, 2017-2032 (USD Million)
TABLE 15. Global Water Extraction Market Size, by Group, 2017-2032 (USD Million)
TABLE 16. Global Water Extraction Market Size, by Country, 2017-2032 (USD Million)
TABLE 17. Global Supercritical CO2 Extraction Market Size, by Region, 2017-2032 (USD Million)
TABLE 18. Global Supercritical CO2 Extraction Market Size, by Group, 2017-2032 (USD Million)
TABLE 19. Global Supercritical CO2 Extraction Market Size, by Country, 2017-2032 (USD Million)
TABLE 20. Global Medical Ophiopogon Japonicus Extract Market Size, by Active Component, 2017-2032 (USD Million)
TABLE 21. Global Steroidal Saponin Market Size, by Region, 2017-2032 (USD Million)
TABLE 22. Global Steroidal Saponin Market Size, by Group, 2017-2032 (USD Million)
TABLE 23. Global Steroidal Saponin Market Size, by Country, 2017-2032 (USD Million)
TABLE 24. Global Polysaccharide Market Size, by Region, 2017-2032 (USD Million)
TABLE 25. Global Polysaccharide Market Size, by Group, 2017-2032 (USD Million)
TABLE 26. Global Polysaccharide Market Size, by Country, 2017-2032 (USD Million)
TABLE 27. Global Medical Ophiopogon Japonicus Extract Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 28. Global Injectable Formulations Market Size, by Region, 2017-2032 (USD Million)
TABLE 29. Global Injectable Formulations Market Size, by Group, 2017-2032 (USD Million)
TABLE 30. Global Injectable Formulations Market Size, by Country, 2017-2032 (USD Million)
TABLE 31. Global Oral Formulations Market Size, by Region, 2017-2032 (USD Million)
TABLE 32. Global Oral Formulations Market Size, by Group, 2017-2032 (USD Million)
TABLE 33. Global Oral Formulations Market Size, by Country, 2017-2032 (USD Million)
TABLE 34. Global Medical Ophiopogon Japonicus Extract Market Size, by Application, 2017-2032 (USD Million)
TABLE 35. Global Respiratory Disease Treatment Market Size, by Region, 2017-2032 (USD Million)
TABLE 36. Global Respiratory Disease Treatment Market Size, by Group, 2017-2032 (USD Million)
TABLE 37. Global Respiratory Disease Treatment Market Size, by Country, 2017-2032 (USD Million)
TABLE 38. Global Cardiovascular Support Therapy Market Size, by Region, 2017-2032 (USD Million)
TABLE 39. Global Cardiovascular Support Therapy Market Size, by Group, 2017-2032 (USD Million)
TABLE 40. Global Cardiovascular Support Therapy Market Size, by Country, 2017-2032 (USD Million)
TABLE 41. Global Anti-Inflammatory Treatment Market Size, by Region, 2017-2032 (USD Million)
TABLE 42. Global Anti-Inflammatory Treatment Market Size, by Group, 2017-2032 (USD Million)
TABLE 43. Global Anti-Inflammatory Treatment Market Size, by Country, 2017-2032 (USD Million)
TABLE 44. Global Medical Ophiopogon Japonicus Extract Market Size, by Region, 2017-2032 (USD Million)
TABLE 45. Asia-Pacific Medical Ophiopogon Japonicus Extract Market Size, by Region, 2017-2032 (USD Million)
TABLE 46. Asia-Pacific Medical Ophiopogon Japonicus Extract Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 47. Asia-Pacific Medical Ophiopogon Japonicus Extract Market Size, by Extraction Method, 2017-2032 (USD Million)
TABLE 48. Asia-Pacific Medical Ophiopogon Japonicus Extract Market Size, by Active Component, 2017-2032 (USD Million)
TABLE 49. Asia-Pacific Medical Ophiopogon Japonicus Extract Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 50. Asia-Pacific Medical Ophiopogon Japonicus Extract Market Size, by Application, 2017-2032 (USD Million)
TABLE 51. North America Medical Ophiopogon Japonicus Extract Market Size, by Region, 2017-2032 (USD Million)
TABLE 52. North America Medical Ophiopogon Japonicus Extract Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 53. North America Medical Ophiopogon Japonicus Extract Market Size, by Extraction Method, 2017-2032 (USD Million)
TABLE 54. North America Medical Ophiopogon Japonicus Extract Market Size, by Active Component, 2017-2032 (USD Million)
TABLE 55. North America Medical Ophiopogon Japonicus Extract Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 56. North America Medical Ophiopogon Japonicus Extract Market Size, by Application, 2017-2032 (USD Million)
TABLE 57. Latin America Medical Ophiopogon Japonicus Extract Market Size, by Region, 2017-2032 (USD Million)
TABLE 58. Latin America Medical Ophiopogon Japonicus Extract Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 59. Latin America Medical Ophiopogon Japonicus Extract Market Size, by Extraction Method, 2017-2032 (USD Million)
TABLE 60. Latin America Medical Ophiopogon Japonicus Extract Market Size, by Active Component, 2017-2032 (USD Million)
TABLE 61. Latin America Medical Ophiopogon Japonicus Extract Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 62. Latin America Medical Ophiopogon Japonicus Extract Market Size, by Application, 2017-2032 (USD Million)
TABLE 63. Europe Medical Ophiopogon Japonicus Extract Market Size, by Region, 2017-2032 (USD Million)
TABLE 64. Europe Medical Ophiopogon Japonicus Extract Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 65. Europe Medical Ophiopogon Japonicus Extract Market Size, by Extraction Method, 2017-2032 (USD Million)
TABLE 66. Europe Medical Ophiopogon Japonicus Extract Market Size, by Active Component, 2017-2032 (USD Million)
TABLE 67. Europe Medical Ophiopogon Japonicus Extract Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 68. Europe Medical Ophiopogon Japonicus Extract Market Size, by Application, 2017-2032 (USD Million)
TABLE 69. Middle East Medical Ophiopogon Japonicus Extract Market Size, by Region, 2017-2032 (USD Million)
TABLE 70. Middle East Medical Ophiopogon Japonicus Extract Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 71. Middle East Medical Ophiopogon Japonicus Extract Market Size, by Extraction Method, 2017-2032 (USD Million)
TABLE 72. Middle East Medical Ophiopogon Japonicus Extract Market Size, by Active Component, 2017-2032 (USD Million)
TABLE 73. Middle East Medical Ophiopogon Japonicus Extract Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 74. Middle East Medical Ophiopogon Japonicus Extract Market Size, by Application, 2017-2032 (USD Million)
TABLE 75. Africa Medical Ophiopogon Japonicus Extract Market Size, by Region, 2017-2032 (USD Million)
TABLE 76. Africa Medical Ophiopogon Japonicus Extract Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 77. Africa Medical Ophiopogon Japonicus Extract Market Size, by Extraction Method, 2017-2032 (USD Million)
TABLE 78. Africa Medical Ophiopogon Japonicus Extract Market Size, by Active Component, 2017-2032 (USD Million)
TABLE 79. Africa Medical Ophiopogon Japonicus Extract Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 80. Africa Medical Ophiopogon Japonicus Extract Market Size, by Application, 2017-2032 (USD Million)
TABLE 81. Global Medical Ophiopogon Japonicus Extract Market Size, by Group, 2017-2032 (USD Million)
TABLE 82. ASEAN Medical Ophiopogon Japonicus Extract Market Size, by Group, 2017-2032 (USD Million)
TABLE 83. ASEAN Medical Ophiopogon Japonicus Extract Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 84. ASEAN Medical Ophiopogon Japonicus Extract Market Size, by Extraction Method, 2017-2032 (USD Million)
TABLE 85. ASEAN Medical Ophiopogon Japonicus Extract Market Size, by Active Component, 2017-2032 (USD Million)
TABLE 86. ASEAN Medical Ophiopogon Japonicus Extract Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 87. ASEAN Medical Ophiopogon Japonicus Extract Market Size, by Application, 2017-2032 (USD Million)
TABLE 88. GCC Medical Ophiopogon Japonicus Extract Market Size, by Group, 2017-2032 (USD Million)
TABLE 89. GCC Medical Ophiopogon Japonicus Extract Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 90. GCC Medical Ophiopogon Japonicus Extract Market Size, by Extraction Method, 2017-2032 (USD Million)
TABLE 91. GCC Medical Ophiopogon Japonicus Extract Market Size, by Active Component, 2017-2032 (USD Million)
TABLE 92. GCC Medical Ophiopogon Japonicus Extract Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 93. GCC Medical Ophiopogon Japonicus Extract Market Size, by Application, 2017-2032 (USD Million)
TABLE 94. European Union Medical Ophiopogon Japonicus Extract Market Size, by Group, 2017-2032 (USD Million)
TABLE 95. European Union Medical Ophiopogon Japonicus Extract Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 96. European Union Medical Ophiopogon Japonicus Extract Market Size, by Extraction Method, 2017-2032 (USD Million)
TABLE 97. European Union Medical Ophiopogon Japonicus Extract Market Size, by Active Component, 2017-2032 (USD Million)
TABLE 98. European Union Medical Ophiopogon Japonicus Extract Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 99. European Union Medical Ophiopogon Japonicus Extract Market Size, by Application, 2017-2032 (USD Million)
TABLE 100. BRICS Medical Ophiopogon Japonicus Extract Market Size, by Group, 2017-2032 (USD Million)
TABLE 101. BRICS Medical Ophiopogon Japonicus Extract Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 102. BRICS Medical Ophiopogon Japonicus Extract Market Size, by Extraction Method, 2017-2032 (USD Million)
TABLE 103. BRICS Medical Ophiopogon Japonicus Extract Market Size, by Active Component, 2017-2032 (USD Million)
TABLE 104. BRICS Medical Ophiopogon Japonicus Extract Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 105. BRICS Medical Ophiopogon Japonicus Extract Market Size, by Application, 2017-2032 (USD Million)
TABLE 106. G7 Medical Ophiopogon Japonicus Extract Market Size, by Group, 2017-2032 (USD Million)
TABLE 107. G7 Medical Ophiopogon Japonicus Extract Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 108. G7 Medical Ophiopogon Japonicus Extract Market Size, by Extraction Method, 2017-2032 (USD Million)
TABLE 109. G7 Medical Ophiopogon Japonicus Extract Market Size, by Active Component, 2017-2032 (USD Million)
TABLE 110. G7 Medical Ophiopogon Japonicus Extract Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 111. G7 Medical Ophiopogon Japonicus Extract Market Size, by Application, 2017-2032 (USD Million)
TABLE 112. NATO Medical Ophiopogon Japonicus Extract Market Size, by Group, 2017-2032 (USD Million)
TABLE 113. NATO Medical Ophiopogon Japonicus Extract Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 114. NATO Medical Ophiopogon Japonicus Extract Market Size, by Extraction Method, 2017-2032 (USD Million)
TABLE 115. NATO Medical Ophiopogon Japonicus Extract Market Size, by Active Component, 2017-2032 (USD Million)
TABLE 116. NATO Medical Ophiopogon Japonicus Extract Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 117. NATO Medical Ophiopogon Japonicus Extract Market Size, by Application, 2017-2032 (USD Million)
TABLE 118. Global Medical Ophiopogon Japonicus Extract Market Size, by Country, 2017-2032 (USD Million)
TABLE 119. United States Medical Ophiopogon Japonicus Extract Market Size, 2017-2032 (USD Million)
TABLE 120. United States Medical Ophiopogon Japonicus Extract Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 121. United States Medical Ophiopogon Japonicus Extract Market Size, by Extraction Method, 2017-2032 (USD Million)
TABLE 122. United States Medical Ophiopogon Japonicus Extract Market Size, by Active Component, 2017-2032 (USD Million)
TABLE 123. United States Medical Ophiopogon Japonicus Extract Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 124. United States Medical Ophiopogon Japonicus Extract Market Size, by Application, 2017-2032 (USD Million)
TABLE 125. Canada Medical Ophiopogon Japonicus Extract Market Size, 2017-2032 (USD Million)
TABLE 126. Canada Medical Ophiopogon Japonicus Extract Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 127. Canada Medical Ophiopogon Japonicus Extract Market Size, by Extraction Method, 2017-2032 (USD Million)
TABLE 128. Canada Medical Ophiopogon Japonicus Extract Market Size, by Active Component, 2017-2032 (USD Million)
TABLE 129. Canada Medical Ophiopogon Japonicus Extract Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 130. Canada Medical Ophiopogon Japonicus Extract Market Size, by Application, 2017-2032 (USD Million)
TABLE 131. Mexico Medical Ophiopogon Japonicus Extract Market Size, 2017-2032 (USD Million)
TABLE 132. Mexico Medical Ophiopogon Japonicus Extract Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 133. Mexico Medical Ophiopogon Japonicus Extract Market Size, by Extraction Method, 2017-2032 (USD Million)
TABLE 134. Mexico Medical Ophiopogon Japonicus Extract Market Size, by Active Component, 2017-2032 (USD Million)
TABLE 135. Mexico Medical Ophiopogon Japonicus Extract Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 136. Mexico Medical Ophiopogon Japonicus Extract Market Size, by Application, 2017-2032 (USD Million)
TABLE 137. Brazil Medical Ophiopogon Japonicus Extract Market Size, 2017-2032 (USD Million)
TABLE 138. Brazil Medical Ophiopogon Japonicus Extract Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 139. Brazil Medical Ophiopogon Japonicus Extract Market Size, by Extraction Method, 2017-2032 (USD Million)
TABLE 140. Brazil Medical Ophiopogon Japonicus Extract Market Size, by Active Component, 2017-2032 (USD Million)
TABLE 141. Brazil Medical Ophiopogon Japonicus Extract Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 142. Brazil Medical Ophiopogon Japonicus Extract Market Size, by Application, 2017-2032 (USD Million)
TABLE 143. United Kingdom Medical Ophiopogon Japonicus Extract Market Size, 2017-2032 (USD Million)
TABLE 144. United Kingdom Medical Ophiopogon Japonicus Extract Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 145. United Kingdom Medical Ophiopogon Japonicus Extract Market Size, by Extraction Method, 2017-2032 (USD Million)
TABLE 146. United Kingdom Medical Ophiopogon Japonicus Extract Market Size, by Active Component, 2017-2032 (USD Million)
TABLE 147. United Kingdom Medical Ophiopogon Japonicus Extract Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 148. United Kingdom Medical Ophiopogon Japonicus Extract Market Size, by Application, 2017-2032 (USD Million)
TABLE 149. Germany Medical Ophiopogon Japonicus Extract Market Size, 2017-2032 (USD Million)
TABLE 150. Germany Medical Ophiopogon Japonicus Extract Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 151. Germany Medical Ophiopogon Japonicus Extract Market Size, by Extraction Method, 2017-2032 (USD Million)
TABLE 152. Germany Medical Ophiopogon Japonicus Extract Market Size, by Active Component, 2017-2032 (USD Million)
TABLE 153. Germany Medical Ophiopogon Japonicus Extract Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 154. Germany Medical Ophiopogon Japonicus Extract Market Size, by Application, 2017-2032 (USD Million)
TABLE 155. France Medical Ophiopogon Japonicus Extract Market Size, 2017-2032 (USD Million)
TABLE 156. France Medical Ophiopogon Japonicus Extract Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 157. France Medical Ophiopogon Japonicus Extract Market Size, by Extraction Method, 2017-2032 (USD Million)
TABLE 158. France Medical Ophiopogon Japonicus Extract Market Size, by Active Component, 2017-2032 (USD Million)
TABLE 159. France Medical Ophiopogon Japonicus Extract Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 160. France Medical Ophiopogon Japonicus Extract Market Size, by Application, 2017-2032 (USD Million)
TABLE 161. Russia Medical Ophiopogon Japonicus Extract Market Size, 2017-2032 (USD Million)
TABLE 162. Russia Medical Ophiopogon Japonicus Extract Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 163. Russia Medical Ophiopogon Japonicus Extract Market Size, by Extraction Method, 2017-2032 (USD Million)
TABLE 164. Russia Medical Ophiopogon Japonicus Extract Market Size, by Active Component, 2017-2032 (USD Million)
TABLE 165. Russia Medical Ophiopogon Japonicus Extract Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 166. Russia Medical Ophiopogon Japonicus Extract Market Size, by Application, 2017-2032 (USD Million)
TABLE 167. Italy Medical Ophiopogon Japonicus Extract Market Size, 2017-2032 (USD Million)
TABLE 168. Italy Medical Ophiopogon Japonicus Extract Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 169. Italy Medical Ophiopogon Japonicus Extract Market Size, by Extraction Method, 2017-2032 (USD Million)
TABLE 170. Italy Medical Ophiopogon Japonicus Extract Market Size, by Active Component, 2017-2032 (USD Million)
TABLE 171. Italy Medical Ophiopogon Japonicus Extract Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 172. Italy Medical Ophiopogon Japonicus Extract Market Size, by Application, 2017-2032 (USD Million)
TABLE 173. Spain Medical Ophiopogon Japonicus Extract Market Size, 2017-2032 (USD Million)
TABLE 174. Spain Medical Ophiopogon Japonicus Extract Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 175. Spain Medical Ophiopogon Japonicus Extract Market Size, by Extraction Method, 2017-2032 (USD Million)
TABLE 176. Spain Medical Ophiopogon Japonicus Extract Market Size, by Active Component, 2017-2032 (USD Million)
TABLE 177. Spain Medical Ophiopogon Japonicus Extract Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 178. Spain Medical Ophiopogon Japonicus Extract Market Size, by Application, 2017-2032 (USD Million)
TABLE 179. China Medical Ophiopogon Japonicus Extract Market Size, 2017-2032 (USD Million)
TABLE 180. China Medical Ophiopogon Japonicus Extract Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 181. China Medical Ophiopogon Japonicus Extract Market Size, by Extraction Method, 2017-2032 (USD Million)
TABLE 182. China Medical Ophiopogon Japonicus Extract Market Size, by Active Component, 2017-2032 (USD Million)
TABLE 183. China Medical Ophiopogon Japonicus Extract Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 184. China Medical Ophiopogon Japonicus Extract Market Size, by Application, 2017-2032 (USD Million)
TABLE 185. India Medical Ophiopogon Japonicus Extract Market Size, 2017-2032 (USD Million)
TABLE 186. India Medical Ophiopogon Japonicus Extract Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 187. India Medical Ophiopogon Japonicus Extract Market Size, by Extraction Method, 2017-2032 (USD Million)
TABLE 188. India Medical Ophiopogon Japonicus Extract Market Size, by Active Component, 2017-2032 (USD Million)
TABLE 189. India Medical Ophiopogon Japonicus Extract Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 190. India Medical Ophiopogon Japonicus Extract Market Size, by Application, 2017-2032 (USD Million)
TABLE 191. Japan Medical Ophiopogon Japonicus Extract Market Size, 2017-2032 (USD Million)
TABLE 192. Japan Medical Ophiopogon Japonicus Extract Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 193. Japan Medical Ophiopogon Japonicus Extract Market Size, by Extraction Method, 2017-2032 (USD Million)
TABLE 194. Japan Medical Ophiopogon Japonicus Extract Market Size, by Active Component, 2017-2032 (USD Million)
TABLE 195. Japan Medical Ophiopogon Japonicus Extract Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 196. Japan Medical Ophiopogon Japonicus Extract Market Size, by Application, 2017-2032 (USD Million)
TABLE 197. Australia Medical Ophiopogon Japonicus Extract Market Size, 2017-2032 (USD Million)
TABLE 198. Australia Medical Ophiopogon Japonicus Extract Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 199. Australia Medical Ophiopogon Japonicus Extract Market Size, by Extraction Method, 2017-2032 (USD Million)
TABLE 200. Australia Medical Ophiopogon Japonicus Extract Market Size, by Active Component, 2017-2032 (USD Million)
TABLE 201. Australia Medical Ophiopogon Japonicus Extract Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 202. Australia Medical Ophiopogon Japonicus Extract Market Size, by Application, 2017-2032 (USD Million)
TABLE 203. South Korea Medical Ophiopogon Japonicus Extract Market Size, 2017-2032 (USD Million)
TABLE 204. South Korea Medical Ophiopogon Japonicus Extract Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 205. South Korea Medical Ophiopogon Japonicus Extract Market Size, by Extraction Method, 2017-2032 (USD Million)
TABLE 206. South Korea Medical Ophiopogon Japonicus Extract Market Size, by Active Component, 2017-2032 (USD Million)
TABLE 207. South Korea Medical Ophiopogon Japonicus Extract Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 208. South Korea Medical Ophiopogon Japonicus Extract Market Size, by Application, 2017-2032 (USD Million)
TABLE 209. Global Medical Ophiopogon Japonicus Extract Market Share, by Key Player, 2025
TABLE 210. Global Medical Ophiopogon Japonicus Extract Market, Key Experts

Companies Mentioned

  • Hubei Biolight Plant Extracts Co., Ltd.
  • Hunan Goldliloo Biotech Co., Ltd.
  • Hunan Nutra-Science Co., Ltd.
  • Hunan Nutraherb Biotech Co., Ltd.
  • Nanjing Natural Extracts Co., Ltd.
  • Shaanxi Green Bio-Engineering Co., Ltd.
  • Shaanxi Huike Botanical Co., Ltd.
  • Shaanxi Shouzhong Herbal Co., Ltd.
  • Shaanxi Yongyuan Bio-Tech Co., Ltd.
  • Shaanxi Zhongxin Natural Products Co., Ltd.
  • Tianjin Zhongxin Pharmaceutical Co., Ltd.
  • Xi’an Freshway Biotech Co., Ltd.
  • Xi’an Lyphar Biotech Co., Ltd.
  • Xi’an Realin Biotech Co., Ltd.
  • Xi’an Ruiting Biotech Co., Ltd.
  • Xi’an Sost Biotech Co., Ltd.
  • Zhejiang Jingxin Pharmaceutical Co., Ltd.
  • Zhejiang Medicine Co., Ltd.

Related Reports

Andrias Japonicus Aquaculture Market Insights 2025, Analysis and Forecast to 2030, by Manufacturers, Regions, Technology, Application, Product Type - Product Image

Andrias Japonicus Aquaculture Market Insights 2025, Analysis and Forecast to 2030, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • 75 Pages
  • Global
From
Ginseng Market - Global Forecast 2026-2032 - Product Image

Ginseng Market - Global Forecast 2026-2032

  • Report
  • 196 Pages
  • Global
From
Shrimp Market Size, Share & Industry Trends Analysis Report By Source (Aquaculture, and Wild), By Distribution Channel (B2B, and B2C), By Form, By Species, By Regional Outlook and Forecast, 2023 - 2030 - Product Image

Shrimp Market Size, Share & Industry Trends Analysis Report By Source (Aquaculture, and Wild), By Distribution Channel (B2B, and B2C), By Form, By Species, By Regional Outlook and Forecast, 2023 - 2030

  • Report
  • Global
From
The World of Sea Cucumbers. Challenges, Advances, and Innovations - Product Image

The World of Sea Cucumbers. Challenges, Advances, and Innovations

  • Book
  • Global
Europe Shrimp Market Size, Share & Industry Trends Analysis Report By Source (Aquaculture, and Wild), By Distribution Channel (B2B, and B2C), By Form, By Species, By Country and Growth Forecast, 2023 - 2030 - Product Image

Europe Shrimp Market Size, Share & Industry Trends Analysis Report By Source (Aquaculture, and Wild), By Distribution Channel (B2B, and B2C), By Form, By Species, By Country and Growth Forecast, 2023 - 2030

  • Report
  • Europe
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.